Hungary - Lipid Modifying Medicine Use
Since 2014, Hungary Lipid Modifying Medicine Use grew 1.4% year on year. With 111.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 17 comparing other countries in Lipid Modifying Medicine Use. Hungary is overtaken by Chile, which was ranked number 16 with 114 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Luxembourg at 105 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark lead the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is an increase of 3.5% compared to 2018. United Kingdom, Norway and Belgium respectively ranked number 2, 3 and 4 in this ranking. Lithuania witnessed the best average annual growth at +18.8% per year, while Slovakia recorded the worst performance at -8.7% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 111.80 |
2018 | 110.10 |
2017 | 109.00 |
2016 | 108.50 |
2015 | 107.60 |
How does Hungary rank in Lipid Modifying Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
16 |
#16
Chile
|
114 | 2019 | +26.9 % | +14.2 % | View data | |
17 |
#17
Hungary
|
112 | 2019 | +1.5 % | +1.4 % | View data | |
18 |
#18
Luxembourg
|
105 | 2019 | -1.2 % | -2.0 % | View data |